Identification of short peptides: optimization of target therapeutic properties of the thymus medicine

What does this source report?

Identifies KE and EDP as minor components of Thymalin and cites earlier detection of EW. KE maps to Vilon; EW maps to Thymogen in the short-peptide catalogue.

Population and setting

Thymalin composition by UHPLC–MS

Evidence type

Analytical / composition study

Preparation

See the original report; formulation details require verification.

Source language

Russian

Title provenance

Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

• EW identification is cited earlier work, not a new EW experiment in this report.
• Presence in the extract does not assign all extract benefits to individual sequences.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Publisher English abstract and reference list checked.

Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.29296/24999490-2021-03-05

Cite and trace this record

Original source: V. Kh. Khavinson, I. K. Zhurkovich, G. A. Ryzhak, E. S. Mironova, N. G. Kovrov. Identification of short peptides: optimization of target therapeutic properties of the thymus medicine Molecular Medicine, 2021 2021.

Molekul research summary: https://molekul.io/research/bio-thymus-identification-2021. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Related compound profiles